Literature DB >> 8540661

A regional study of thyroidectomy: surgical pathology suggests scope to improve quality and reduce cost.

G Asimakopoulos1, T Loosemore, R C Bowyer, G McKee, A E Giddings.   

Abstract

This study of thyroid histopathological data from hospitals in the South West Thames region was undertaken to assess current practice and the scope for improvement. Over a 6 month period, 186 thyroid operations were performed on 179 patients at eight hospitals serving almost 1.7 million people. The frequency of thyroidectomy in different hospitals varied from 13 to 35 per 100,000 per year and 6.4% of the operations were second thyroidectomies. Benign multinodular goitre was the most common histological finding (34%). A benign solitary nodule was found in 36% and malignancy in 8.4% of the specimens. Correlation of histological analysis and type of operation suggested that a variety of operations were performed for the same pathological condition and that some operations were diagnostic procedures only. Overall, 63 of the 186 operations (34%) might have been avoided by a firm preoperative diagnosis. Only 67 thyroid fine needle aspiration biopsies (FNAC) were performed at the eight hospitals during the study period. Only 15 (8%) of the patients who underwent thyroid operation had been investigated by FNAC. Reduction in thyroid surgery through more widespread use of FNAC could result in savings of 100,000 pounds per million population per year. Regional activity data show that more than 50 surgeons currently undertake a workload of less than 500 thyroidectomies each year. Increased subspecialisation may be required to reduce costs and raise standards.

Entities:  

Mesh:

Year:  1995        PMID: 8540661      PMCID: PMC2502468     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  20 in total

Review 1.  Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration.

Authors:  M W Ashcraft; A J Van Herle
Journal:  Head Neck Surg       Date:  1981 Mar-Apr

2.  Treatment of thyroid carcinoma in 107 cases.

Authors:  D C Bartolo; P H Kay; C H Talbot
Journal:  Ann R Coll Surg Engl       Date:  1983-09       Impact factor: 1.891

3.  Surgical treatment for thyroid cancer.

Authors:  O H Beahrs
Journal:  Br J Surg       Date:  1984-12       Impact factor: 6.939

4.  Aspiration biopsy cytology in diagnosis of thyroid cancer.

Authors:  T Löwhagen; J S Willems; G Lundell; R Sundblad; P O Granberg
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

5.  The spectrum of thyroid disease in a community: the Whickham survey.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

6.  Solitary thyroid nodule: audit shows improved care requires cytological diagnosis.

Authors:  N R Wetzig; A E Giddings
Journal:  Ann R Coll Surg Engl       Date:  1989-09       Impact factor: 1.891

7.  Cancer in thyroid nodules. A community hospital survey.

Authors:  E E Werk; B M Vernon; J J Gonzalez; P C Ungaro; R C McCoy
Journal:  Arch Intern Med       Date:  1984-03

8.  Fine-needle aspiration biopsy and the diagnosis of thyroid cancer.

Authors:  J B Anderson; A J Webb
Journal:  Br J Surg       Date:  1987-04       Impact factor: 6.939

9.  Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care.

Authors:  B Hamberger; H Gharib; L J Melton; J R Goellner; A R Zinsmeister
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

Review 10.  Management of the solitary thyroid nodule.

Authors:  M H Wheeler
Journal:  J R Soc Med       Date:  1988-08       Impact factor: 18.000

View more
  2 in total

1.  Improving the results of thyroid surgery. Introduction.

Authors:  A E Giddings
Journal:  J R Soc Med       Date:  1998       Impact factor: 18.000

2.  The history of thyroidectomy.

Authors:  A E Giddings
Journal:  J R Soc Med       Date:  1998       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.